Portal de recerca
ENSAYO CLINICO COMPARATIVO, ALEATORIZADO, ABIERTO, MULTICENTRICO, PARA VALORAR LA SEGURIDAD Y LA EFICACIA DE AZITROMICINA INTRAVENOSA/ORAL COMPARADA CON CLARITROMICINA INTRAVENOS/ORAL EN EL TRATAMIENTO DE NEUMONIAS CAUSADAS POR LEGIONELA PNEUMOPHILLA.
Dades bàsiques
- Protocol:
- AO66-1040
- EURDRACT:
- NO PROCEDE
- NCT:
- Centre:
- Any inici:
- Any de finalització:
- 2002
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
Acute and sustained endothelial damage in COVID-19
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.OA3966. 2021
Acute and sustained increase in endothelial biomarkers in COVID-19.
Méndez R; (...); Menéndez R
Article. 10.1136/thoraxjnl-2020-216797. 2021
Asthma Exists in Older People too.
Perpiñá Tordera M, Álvarez Gutiérrez FJ, Blanco Aparicio M
Editorial Material. 10.1016/j.arbres.2022.02.010. 2022
BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES.
Fernández LS; (...); Jorge RZ
Article. 10.1016/j.ijid.2021.11.023. 2022
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1038/s41598-024-62718-4. 2024
Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.
Wang X; (...); Barreiro E
Article. 10.3390/biomedicines10051044. 2022
Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
Méndez R; (...); Menéndez R
Article. 10.1016/j.chest.2021.10.013. 2021
COVID-19 in young and middle aged adults. Predictors of poor evolution and clinical differences
Tabernero Huguet, Eva; (...); Zalacain Jorge, Rafael
Meeting Abstract. 10.1183/13993003.congress-2021.OA88. 2021
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
Tabernero E; (...); Zalacain R
Article. 10.1007/s15010-021-01684-9. 2021
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach.
Garcia-Vidal, Carolina; (...); Soriano, Alex
Article. 10.1002/jmv.70276. 2025
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations.
Aliberti S; (...); Chalmers JD
Article. 10.1016/S2213-2600(21)00277-0. 2021
Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study
Wang, XJ; (...); Barreiro, E
Article. 10.3390/biomedicines9080905. 2021
Early profiling of low-risk SARS-CoV-2 pneumonia for ward allocation
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.PA3659. 2021
Early recognition of low-risk SARS-CoV-2 pneumonia: A model validated with initial data and IDSA/ATS minor criteria.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1016/j.chest.2022.05.013. 2022
Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.
González-Jiménez P; (...); Méndez R
Article. 10.3390/biomedicines12102413. 2024
Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms241713194. 2023
Expert consensus recommendations for the management of asthma in older adults.
Perpiñá M; (...); Blanco-Aparicio M
Practice Guideline. 10.1016/j.medcli.2021.04.028. 2021
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
Scioscia, G.; (...); Torres, A.
Article. 10.1016/j.arbres.2022.04.008. 2022
Herpes Zoster Virus: Should Patients With Chronic Respiratory Diseases Be Vaccinated?
Menendez, Rosario, Gonzalez-Jimenez, Paula, Mendez, Raul
Editorial Material. 10.1016/j.arbres.2023.07.012. 2023
Immune treatment in COVID-19.
Menendez, Rosario; (...); Mendez, Raul
Article. 10.37201/req/s01.14.2022. 2022
Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis.
Garcia Clemente, Marta; (...); Martínez-García MÁ
Article. 10.3390/jcm11143960. 2022
Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia.
Bronte, O.; (...); Espana, P. P.
Article. 10.1016/j.scitotenv.2023.164877. 2023
Impact of Time to Intubation on Mortality and Pulmonary Sequelae in Critically Ill COVID-19 Patients: A Prospective Cohort
Gonzalez, J.; (...); Barbe, F.
Meeting Abstract. 2022
Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
Campos, Catia Cilloniz; (...); Soriano, Alex
Meeting Abstract. 10.1183/13993003.congress-2021.PA1753. 2021
Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis.
Cilloniz, Catia; (...); Soriano, Alex
Article. 10.1007/s10096-021-04378-0. 2022
Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia
Ocana, R. Mendez; (...); Menendez, R.
Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Mendez, Raul; (...); NEUMONAC and RECOVID
Article. 10.3389/fmed.2023.1236142. 2023
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
González J; (...); Barbé F
Article. 10.1016/j.arbres.2022.12.017. 2023
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact.
Garcia-Vidal C; (...); Soriano A
Article. 10.1007/s40121-024-00938-x. 2024
Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19
Bekki, Amina; (...); Angel Martinez-Garcia, Miguel
Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021
Long-term Mortality in COVID-19 and Community-Acquired Pneumonia: A One-year Follow-up Study
Ocana, R. Mendez; (...); NEUMONAC RECOVID
Meeting Abstract. 2023
Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study.
Mendez, Raul; (...); Menendez, Rosario
Letter. 10.1111/joim.13389. 2022
Machine-Learning Model for Mortality Prediction in Patients with Community-acquired Pneumonia: Development and validation study.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.chest.2022.07.005. 2022
Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms24076690. 2023
Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality
Garcia-Garcia, Fernando; (...); Jorge, Rafael Zalacain
Article. 10.1186/s41479-024-00132-0. 2024
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
Figueira-Goncalves, Juan Marco; (...); Menendez, Rosario
Article. 10.2147/COPD.S428316. 2023
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
Wang, XJ; (...); Barreiro, E
Article. 10.3390/ijerph18168431. 2021
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016-2020: The CAPA Study
Menendez, Rosario; (...); Gessner, Bradford D.
Article. 10.3390/microorganisms11112781. 2023
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study.
Benítez ID; (...); Barbé F
Article. 10.1016/j.lanepe.2022.100422. 2022
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1111/joim.13642. 2023
Social Determinants of Respiratory Health: Opening the Door.
Perpina-Tordera, Miguel, Almonacid, Carlos
Editorial Material. 10.1016/j.arbres.2024.07.022. 2024
Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study.
Wang X; (...); Barreiro E
Article. 10.3390/biomedicines10020225. 2022
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
The evolution and distribution of pneumococcal serotypes in adults hospitalized with community acquired pneumonia in Spain using serotype specific urinary antigen detection test: the CAPA study, 2011-2018.
Torres, Antoni; (...); Gessner, Bradford D
Article. 10.1093/cid/ciab307. 2021
Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia.
Méndez R; (...); Menéndez R
Article. 10.1055/s-0043-1778139. 2024
Understanding the Host in the Management of Pneumonia An Official American Thoracic Society Workshop Report
Dela Cruz, Charles S.; (...); Amer Thoracic Soc Assembly Pulm In
Article. 10.1513/AnnalsATS.202102-209ST. 2021
Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.arbres.2022.08.012. 2023